STML

Stemline Therapeutics, Inc.

STML

Nicht mehr börsennotiert

STML wurde am 9. Juni 2020 von der Börse genommen.

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity Investments Boston, Massachusetts	21,9 Mio. $	-1,45 Mio. $	-104.500	-5 %
2	2 Franklin Resources San Mateo, California	18,3 Mio. $	+3,29 Mio. $	+236.800	+18 %
3	3 TimesSquare Capital Management New York	14,4 Mio. $	-1,22 Mio. $	-87.700	-7 %
4	4 Eventide Asset Management Boston, Massachusetts	8,29 Mio. $	+1,17 Mio. $	+84.050	+14 %
5	5 Farallon Capital Management San Francisco, California	7,92 Mio. $	–	–	–
6	6 Great Point Partners Greenwich, Connecticut	5,59 Mio. $	–	–	–
7	7 Goldman Sachs New York	5,42 Mio. $	-12.093 $	-871	-0,2 %
8	8 VHCP Management New York	5,31 Mio. $	–	–	–
9	9 Vanguard Group Malvern, Pennsylvania	5,13 Mio. $	+92.458 $	+6.659	+2 %
10	10 BlackRock Fund Advisors San Francisco, California	4,67 Mio. $	-218.349 $	-15.726	-4 %
11	11 Millennium Management New York	4,11 Mio. $	+216.155 $	+15.568	+5 %
12	BBA 12 Baker Bros. Advisors New York	3,92 Mio. $	–	–	–
13	13 State Street Boston, Massachusetts	2,23 Mio. $	+113.159 $	+8.150	+4 %
14	14 Mackenzie Financial Toronto Ontario, Ontario, Canada	1,95 Mio. $	+917.772 $	+66.100	+66 %
15	15 Northern Trust Chicago, Illinois	1,88 Mio. $	+230.151 $	+16.576	+12 %
16	16 Invesco Atlanta, Georgia	1,54 Mio. $	-25.159 $	-1.812	-1 %
17	TC 17 TFS Capital West Chester, Pennsylvania	1,53 Mio. $	-1,8 Mio. $	-129.942	-50 %
18	18 BlackRock Institutional Trust San Francisco, California	1,52 Mio. $	-153.494 $	-11.055	-8 %
19	19 Geode Capital Management Boston, Massachusetts	1,11 Mio. $	+50.804 $	+3.659	+4 %
20	20 Perceptive Advisors New York	933.000 $	–	–	–
21	TI 21 Telemetry Investments New York	930.000 $	+333.230 $	+24.000	+44 %
22	22 TIAA CREF Investment Management New York	884.000 $	+229.943 $	+16.561	+28 %
23	23 Opus Point Partners Management New York	883.000 $	–	–	–
24	24 Bank of New York Mellon New York	876.000 $	-67.243 $	-4.843	-6 %
25	25 Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland	712.000 $	+523.449 $	+37.700	+165 %

Stemline Therapeutics, Inc. STML

Stemline Therapeutics, Inc.

STML